WallStreetZenWallStreetZen

NASDAQ: KYMR
Kymera Therapeutics Inc Stock Ownership - Who owns Kymera Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Kymera Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Bruce BoothDirector2024-03-158,126$39.31
$319.43kSell
Bruce BoothDirector2024-03-15329$41.23
$13.56kSell
Bruce BoothDirector2024-03-1549,591$40.62
$2.01MSell
Bruce BoothDirector2024-03-1510,411$40.62
$422.89kSell
Bruce BoothDirector2024-03-151,714$39.31
$67.38kSell
Bruce BoothDirector2024-03-151,593$41.23
$65.68kSell
Bruce BoothDirector2024-03-1410,846$40.66
$441.00kSell
Bruce BoothDirector2024-03-1434,473$39.73
$1.37MSell
Bruce BoothDirector2024-03-14154$41.51
$6.39kSell
Bruce BoothDirector2024-03-142,233$40.66
$90.79kSell

1 of 7

KYMR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KYMR insiders and whales buy or sell their stock.

KYMR Shareholders

What type of owners hold Kymera Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP9.81%5,995,928$200.08MInstitution
Atlas Venture Life Science Advisors LLC9.59%5,858,262$195.49MInstitution
Atlas Venture Associates X LP9.43%5,763,012$192.31MInsider
Baker Bros Advisors LP9.03%5,516,985$184.10MInsider
Atlas Venture Fund X LP9.01%5,504,905$183.70MInsider
Price T Rowe Associates Inc8.73%5,335,712$178.05MInstitution
Bvf Inc8.45%5,161,801$172.25MInstitution
Wellington Management Group LLP7.88%4,815,558$160.70MInstitution
Vanguard Group Inc6.54%3,997,564$133.40MInstitution
Avoro Capital Advisors LLC6.18%3,775,000$125.97MInstitution

1 of 3

KYMR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KYMR71.48%28.52%Net SellingNet Selling
CLDX82.75%17.25%Net BuyingNet Buying
DYN65.80%34.20%Net SellingNet Selling
GERN72.04%1.23%Net Buying
TGTX53.78%46.22%Net SellingNet Selling
View Top Biotech Stocks

Kymera Therapeutics Stock Ownership FAQ

Who owns Kymera Therapeutics?

Kymera Therapeutics (NASDAQ: KYMR) is owned by 98.88% institutional shareholders, 39.46% Kymera Therapeutics insiders, and 0.00% retail investors. Atlas Venture Associates X LP is the largest individual Kymera Therapeutics shareholder, owning 5.76M shares representing 9.43% of the company. Atlas Venture Associates X LP's Kymera Therapeutics shares are currently valued at $192.31M.

If you're new to stock investing, here's how to buy Kymera Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.